Newsfeeds - Spark Newswire

2 minute read

Novan Acquires EPI Health For Purchase Price Totaling $27.5M

Today, 1:56 PM

– EPI Health promotes four prescription products posting 2021 operating revenue of $17.6 million – – Acquisition forward integrates Novan with complementary commercial infrastructure

NOVN

16 minute read

Penny Stocks

NOVN: A Banner Year for Novan – 2021 Results

By Zacks Small Cap Research

Today, 1:56 PM

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT

NOVN

1 minute read

Novan Shares Spike Higher As Zack’s Small Cap Research Out With $41 Valuation Target

By Benzinga Newsdesk

Today, 1:56 PM

https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_03072022_NOVN_Vandermosten.pdf

NOVN

11 minute read

Earnings Scheduled For February 22, 2022

By Benzinga Insights

Today, 1:56 PM

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million.

1 minute read

Legal
News

Novan Granted Canadian Patent Titled ‘TOPICAL GELS COMPRISING NITRIC OXIDE-RELEASING POLYSILOXANE MACROMOLECULES AND USES THEREOF’

By Benzinga Newsdesk

Today, 1:56 PM

https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/3062005/summary.html

NOVN

3 minute read

52 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:56 PM

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 29.8% to settle at $0.5969.

AEHL

3 minute read

34 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 1:56 PM

Gainers Biofrontera Inc. (NASDAQ: BFRI) shares climbed 30.7% to $4.4095 after the company provided an update on patient recruitment for the Phase III study for the treatment of sBCC with Ameluz-PDT.

AGIL

4 minute read

64 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:56 PM

Gainers

AKTS

1 minute read

Novan Q3 EPS $(0.34) Beats $(0.42) Estimate, Sales $737.00K Miss $750.00K Estimate

By Benzinga Newsdesk

Today, 1:56 PM

Novan (NASDAQ:NOVN) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.42) by 19.05 percent. This is a 32 percent increase over losses of $(0.50) per share from the same

NOVN